| Literature DB >> 36061040 |
Liang Wang1, Xiaoqian Chen1, Wei Miao1, Yubin Ma1, Xinfu Ma1, Chun Wang1, Xiaobo Cao1, Hongyin Xu1, Jiajia Wei1, Su Yan1.
Abstract
Background: The method of operation and the range of resection for Siewert II adenocarcinoma of the esophagogastric junction (AEG) remain controversial. This study aims to evaluate the safety, feasibility, and short-term postoperative effect of total laparoscopic versus laparoscopic-assisted transabdominal posterior mediastinal digestive tract reconstruction in the treatment of Siewert II AEG.Entities:
Keywords: Siewert type II; adenocarcinoma of the esophagogastric junction; digestive tract reconstruction; posterior mediastinum; total laparoscopy
Year: 2022 PMID: 36061040 PMCID: PMC9437538 DOI: 10.3389/fsurg.2022.874857
Source DB: PubMed Journal: Front Surg ISSN: 2296-875X
Preoperative patient demographic information.
| Laparoscopy-assisted group ( | Totally endoscopic Group ( | ||
|---|---|---|---|
| Age (years) | 62.01 ± 8.31 | 59.72 ± 8.64 | 0.170 |
| Gender | |||
| Male | 50 (78.13%) | 38 (86.36%) | 0.279 |
| Female | 14 (21.87%) | 6 (13.64%) | |
| BMI (Kg/m2) | 21.97 (20.33–22.96) | 22.08 (21.14–23.18) | 0.058 |
| ASA grade | |||
| I | 35 (54.68%) | 31 (70.45%) | 0.194 |
| II | 22 (34.37%) | 7 (15.91%) | |
| III | 7 (10.93%) | 6 (13.63%) | |
| Preoperative CEA (ng/L) | 2.44 (1.55–10.80) | 2.12 (1.45–4.96) | 0.348 |
| preoperative examination time (d) | 9 (7-10) | 9 (7-10) | 0.947 |
| Previous surgical history | |||
| No | 38 (59.37%) | 33 (86.40%) | 0.093 |
| Yes | 26 (40.62%) | 11 (13.60%) | |
| Previous abdominal surgical history | |||
| No | 53 (82.81%) | 38 (86.36%) | 0.083 |
| Yes | 11 (17.19%) | 6 (13.64%) | |
| Basic diseases | |||
| No | 42 (65.62%) | 32 (72.72%) | |
| Hypertension | 8 (12.50%) | 2 (4.54%) | |
| Diabetes | 4 (6.25%) | 4 (9.09%) | 0.663 |
| Chronic bronchitis | 6 (9.37%) | 4 (9.09%) | |
| Heart disease | 4 (6.25%) | 2 (4.54%) | |
BMI, body mass index; ASA , American Society of Anesthesiologists; CEA, carcinoembryonic antigen
Figure 1(A) Location of intraoperative incision; (B) postoperative abdominal incision was performed.
Figure 2(A) Enter the left chest; (B) leave the esophageal stump to use traction line for esophagus jejunum anastomosis; (C) inspire stapling anastomosis. (D) On the left side of the diaphragm foot, suture fixation is completed. (E) Diaphragm on the right foot with jejunum output auspicious suture fixation has been completed. (F) Through the left rear of esophageal hiatus, put drainage tube into mediastinum anastomosis. (G) Side of the stomach tube toward the head direction of traction, perform the stomach tube length measurement to ensure that the tubular stomach without any tension. (H) Ensure mesangial esophagus and aorta front fascia surface's integrity. (I) Go through the right side of the esophageal clearance and pay attention not to damage the mediastinal pleura as far as possible.
Figure 3(A) Effect of different surgical methods on operation time; (B) effect of different surgical methods on the time of digestive tract reconstruction; (C) effect of different surgical methods on intraoperative blood loss.
Figure 4(A) Pathology results from the totally endoscopic group by total gastrectomy; (B) pathology results from the laparoscopy-assisted group by total gastrectomy; (C) pathology results from the totally endoscopic group by proximal gastrectomy; (D) pathology results from the laparoscopy-assisted group by proximal gastrectomy.
intraoperative correlation index.
| Laparoscopy assisted group ( | Totally endoscopic group ( | ||
|---|---|---|---|
| Surgical procedure | |||
| TG | 28 (43.75%) | 18 (40.91%) | 0.769 |
| PG | 36 (56.25%) | 26 (59.09%) | |
| Operation Time (min) | 153.00 (132.00–170.00) | 173.00 (160.00–199.00) |
|
| Reconstruction time of the digestive tract (min) | 23.00 (20.00–25.00) | 25.50 (23.00–30.00) |
|
| Blood loss (ml) | 100.00 (100.00–110.00) | 50.00 (20.00–60.00) |
|
| Surface area of serosa (cm) | 0.00 (0.00–0.95) | 0.00 (0.00–2.00) | 0.188 |
| Near cutting edge (cm) | 3.00 (3.00–3.00) | 3.00 (2.50–3.00) | 0.336 |
| Distance between tumor distal end and EGJ line (cm) | 3.00 (2.65–5.37) | 3.00 (2.35–5.27) | 0.259 |
| Number of mediastinal lymphadenectomy | 0.00 (0.00–0.00) | 0.00 (0.00–2.00) |
|
| Number of positive mediastinal lymph nodes | 0.00 (0.00–0.00) | 0.00 (0.00–0.00) | 0.087 |
| Number of abdominal lymph node dissections | 23.00 (18.00–30.00) | 26.00 (22.00–30.00) | 0.160 |
| Positive number of abdominal lymph nodes | 1.00 (0.00–5.00) | 1.00 (0.00–3.00) | 0.723 |
PG, proximal gastrectomy; TG, total gastrectomy; min,minute; ml,milliliter; cm, centimetre.
Bold values indicate, when the test P < 0.05, the difference was statistically significant.
Figure 5(A) Effect of different surgical methods on postoperative pain from 12 to 120 h; (B) effect of different surgical methods on postoperative hospital stay.
postoperative recovery index.
| Laparoscopy-assisted group ( | Totally endoscopic group ( | ||
|---|---|---|---|
| Postoperative CA19-9 (U/ml) | 5.94 (2.82–11.50) | 5.56 (3.26–9.56) | 0.599 |
| Postoperative CEA (ng/L) | 1.73 (1.26–4.99) | 2.44 (1.30–3.44) | 0.468 |
| The first time to get out of bed after operation (days) | 1.56 ± 0.65 | 1.27 ± 0.45 | 0.070 |
| Postoperative exhaust time (days) | 3.00 (3.00–4.00) | 3.00 (2.00–3.00) |
|
| Postoperative defecation time (days) | 4.00 (3.00–4.00) | 3.00 (3.00–3.00) |
|
| Time of fluid diet after the operation (days) | 10.00 (9.00–12.00) | 9.00 (9.00–11.00) |
|
| Postoperative half-fluid diet time (days) | 13.00 (12.25–14.00) | 12.00 (11.00–13.75) |
|
| Postoperative hospitalization (days) | 11.00 (10.00–12.00) | 10.00 (9.00–11.00) |
|
| Length of postoperative hospital stay (days) | 11.00 (10.00–12.00) | 10.00 (9.00–11.00) |
|
| Operation expenses (CNY) | 27650.00 (20680.00–32928.50) | 29086.00 (26272.00–33738.25) | 0.087 |
| Total hospitalization expenses (CNY) | 51061.51 (47898.46–58303.01) | 52771.10 (48762.13–70265.04) | 0.310 |
CA19-9,carbohydrate antigen 19-9; CEA, carcinoembryonic antigen; d,day; CNY,Chinese Yuan.
Bold values indicate, when the test P < 0.05, the difference was statistically significant.
postoperative recovery index.
| Postoperative VAS score | Laparoscopy-assisted group ( | Totally endoscopic group ( | |
|---|---|---|---|
| VAS score 12 h after the operation | 4.04 ± 1.36 | 3.36 ± 0.86 |
|
| VAS score 24 h after the operation | 3.90 ± 1.28 | 3.31 ± 1.094 |
|
| VAS score 48 h after the operation | 3.35 ± 1.37 | 2.84 ± 0.88 |
|
| VAS score 72 h after the operation | 2.98 ± 1.18 | 2.52 ± 0.73 |
|
| VAS score 96 h after the operation | 2.07 ± 0.64 | 2.04 ± 0.68 | 0.802 |
| VAS score 120 h after the operation | 1.56 ± 0.77 | 1.54 ± 0.58 | 0.902 |
VAS,visual analogue score.
Bold values indicate, when the test P < 0.05, the difference was statistically significant.
Figure 6(A) Effect of different surgical methods on the incidence of postoperative complications; (B) effect of different surgical methods on overall survival rate.
postoperative pathological indexes.
| Laparoscopy-assisted group ( | Totally endoscopic group ( | ||
|---|---|---|---|
| Postoperative T staging | |||
| T1 | 9 (14.06%) | 10 (22.73%) | 0.446 |
| T2 | 29(45.31%) | 16 (36.36%) | |
| T3 | 26 (40.63%) | 18 (40.91%) | |
| Postoperative N staging | |||
| N0 | 34 (53.13%) | 19 (43.18%) | 0.579 |
| N1 | 21 (32.81%) | 20 (45.45%) | |
| N2 | 8 (12.50%) | 4 (9.09%) | |
| N3 | 1 (1.56%) | 1 (2.28%) | |
| Differentiated degree | |||
| Poorly differentiated | 30 (46.88%) | 26 (59.09%) | |
| Moderately differentiated | 26 (40.62%) | 14 (31.82%) | 0.456 |
| High differentiated | 8 (12.50%) | 4 (9.09%) | |
| Near margin status | |||
| Positive | 1 (1.56%) | 0 (0%) | 0.405 |
| Negative | 63 (98.44%) | 44 (100%) | |
| Distal margin status | |||
| Positive | 0 (0%) | 1 (2.27%) | 0.226 |
| Negative | 64 (100%) | 43 (97.73%) | |
postoperative safety index.
| Laparoscopy-assisted group ( | Totally endoscopic Group ( | ||
|---|---|---|---|
| Morbidity < grade III* | 17 (26.56%) | 10 (22.72%) | 0.651 |
| Anastomotic leakage | 6 (9.37%) | 4 (9.09%) | 0.960 |
| Anastomotic bleeding | 3 (4.68%) | 1 (2.27%) | 0.514 |
| Pulmonary-associated complication | 2 (3.12%) | 3 (6.81%) | 0.369 |
| Anastomoti stenosis | 2 (3.12%) | 0 (0%) | 0.237 |
| Abdominal incision infection | 2 (3.12%) | 2 (4.54%) | 0.701 |
| Pancreatic leakage | 2 (3.12%) | 0 (0%) | 0.237 |
| Relapse rate | 2 (3.12%) | 2 (4.54%) | 0.701 |
| Mortality | 3 (4.68%) | 2 (4.54%) | 0.972 |
*According to the Clavien-Dindo grading system.
Clinicopathological factors in patients with or without morbidity ≤ grade IIIa.
| Morbidity (–) ( | Morbidity (+) ( | ||
|---|---|---|---|
| Age (years) | 61.00 (54.00–67.00) | 63.00 (60.00–65.00) | 0.757 |
| Sex | 0.055 | ||
| Male | 76 (93.83%) | 22 (81.48%) | |
| Female | 5 (6.17%) | 5 (18.52%) | |
| Body mass index (Kg/m2) | 22.04 (20.52–24.93) | 21.63 (20.39–23.00) | 0.081 |
| Tumor size (cm) | 5.60 (4.15–7.15) | 6.00 (4.00–8.40) | 0.168 |
| Laparoscopy assisted group | 45 (55.56%) | 19 (70.37%) | 0.175 |
| Totally endoscopic group | 36 (44.44%) | 8 (29.63%) | |
| Surgical procedure | 0.261 | ||
| PG | 49 (60.49%) | 13 (48.15%) | |
| TG | 32 (39.51%) | 14 (51.85%) | |
| Operation time (min) | 156.00 (120.00–170.00) | 160.00 (120.00–180.00) | 0.131 |
| Blood loss (ml) | 26.00 (15.00–40.00) | 40.00 (15.00–50.00) | 0.094 |
PG, proximal gastrectomy; TG, total gastrectomy.